Richard J Perner

USPTO Granted Patents = 22 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 11)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 117(Granted Patents)

Company Filing History:

13 out of 4,177

Abbott Laboratories Corporation

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2017

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9751850 - TRPA1 antagonists (2017-09-05),

2. 9108905 - TRPA1 antagonists (2015-08-18),

3. 8877784 - TRPA1 antagonists (2014-11-04),

4. 8815930 - Compounds that inhibit TRPV1 and uses thereof (2014-08-26),

5. 8669255 - Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers (2014-03-11),

6. 8648074 - [object Object] (2014-02-11),

7. 8609692 - TRPV1 antagonists (2013-12-17),

8. 8604053 - TRPV1 antagonists (2013-12-10),

9. 8247413 - Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor (2012-08-21),

10. 8044069 - Compounds as calcium channel blockers (2011-10-25),

11. 7998993 - TRPV1 antagonists (2011-08-16),

12. 7902236 - Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof (2011-03-08),

13. 7767705 - Compounds that inhibit TRPV1 and uses thereof (2010-08-03),

14. 7504520 - Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof (2009-03-17),

15. 7335678 - Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor (2008-02-26),

Title: The Inventor Spotlight: Richard J Perner

Introduction: Meet Richard J Perner, a prolific inventor based in Gurnee, IL, with an impressive track record of 22 patents to his name. His groundbreaking work in the field of TRPA1 antagonists is revolutionizing the treatment of various conditions and disorders.

Latest Patents: Richard J Perner's latest patents focus on TRPA1 antagonists - compounds that have shown great promise in treating a range of conditions. These compounds, as described in formula (I), have paved the way for innovative compositions and methods for addressing different health issues. His dedication to advancing pharmaceutical research is truly commendable.

Career Highlights: With a rich background in the industry, Richard J Perner has made significant contributions during his tenure at Abbott Laboratories Corporation and AbbVie Inc. His expertise and innovative spirit have been instrumental in driving forward groundbreaking research and development initiatives.

Collaborations: Throughout his career, Richard J Perner has collaborated with esteemed professionals in the field, including coworkers such as Stanley DiDomenico and Arthur Gomtsyan. These collaborations have fostered a culture of innovation and excellence, leading to the successful development of transformative healthcare solutions.

Conclusion: In conclusion, Richard J Perner stands as a shining example of an inventor whose work is making a tangible difference in the world of pharmaceuticals. His dedication to pushing the boundaries of scientific discovery and his collaborative approach underscore the importance of teamwork and innovation in driving progress. With his continued efforts, the future of healthcare looks brighter than ever before.

This text is generated by artificial intelligence and may not be accurate.